Clinical Trials on Androgen Profile in Spain
Total 19 results
-
IVI MadridCompletedInflammatory Markers | Androgen Profile | IVF OutcomeSpain
-
Instituto Valenciano de Infertilidad, IVI VALENCIAIgenomixCompletedGenomic Human Endometrial Expression ProfileSpain
-
Instituto BernabeuNot yet recruiting
-
GuerbetCompletedGeneral Safety Profile of DOTAREMArgentina, China, France, Spain, India, United Kingdom, Austria, Germany, Italy, Saudi Arabia
-
Clinica Universidad de Navarra, Universidad de...CompletedLipid Profile | Hyperglycemia, Postprandial | Feeding Behaviors | Antioxidant | PostprandialSpain
-
Applied Biology, Inc.Hospital Universitario Ramon y CajalWithdrawnCOVID-19 | SARS-CoV 2 | COVID | Androgenetic Alopecia | Androgen Deficiency | Androgen Receptor AbnormalSpain
-
BayerCompletedMale | Androgens (Deficiency)Italy, Spain, Austria, Finland, United Kingdom, Germany, Ireland, Sweden
-
Sylentis, S.A.CompletedChoroidal Neovascularization | Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersSpain
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
HealthCore-NERIBayer; Besins HealthcareCompletedMale Hypogonadism | Testosterone Deficiency | Androgen DeficiencyItaly, United Kingdom, Spain, Netherlands, Germany, Sweden
-
BayerCompletedUterine Bleeding Profile PredictionSpain, Germany, Sweden, Mexico, Brazil, Denmark
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
Instituto de Investigación en Oncología Radioterápica...RecruitingProstate Cancer | Biochemical Recurrence | Androgen Deprivation Therapy | Salvage Radiotherapy | Metastases-free SurvivalSpain
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
-
dr. Laura C. G. de Graaff-HerderNot yet recruitingCongenital Adrenal Hyperplasia | Hypogonadotropic Hypogonadism | Growth Hormone Deficiency | Turner Syndrome | Addison's Disease | Klinefelter Syndrome | Combined Pituitary Hormone Deficiency | Androgen Insensitivity Syndrome | Thyroid DysgenesisSpain, United Kingdom, Belgium, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingProstatic NeoplasmsBelgium, Canada, Spain, Germany, Austria, Netherlands, United Kingdom, United States, France, Switzerland, Sweden, Slovakia, Poland, Czechia
-
InvestigatorUrologyIBSALInstituto de Investigación Biomédica de SalamancaUnknownEstablish the Efficacy Between the Four Schemes in Terms of the Aggressiveness of the Tumors According to the Gleason Classification | Establish the Efficacy Between the Four Schemes in Terms of Morbidity Associated With the Technique | Establish the Efficacy Between the Four Schemes... and other conditionsSpain
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece